demonstrated that PDACs have a paucity of cDCs and increasing cDC number through FLT3L treatment restored immune responses to cancer antigens, inhibited tumor growth, reversed fibrosis, and sensitized tumors to radiation therapy (69). The gene discussed is FLT3LG; the disease is cancer.